About
Camena develops the gSynth® platform, an AI-driven DNA synthesis technology that enables the rapid, high-fidelity production of complex, transfection-ready DNA constructs to accelerate drug discovery and development of gene and cell therapies.
Explore Camena's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.